Published on in Vol 6, No 3 (2017): March

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Ian Gilron 1, MSc, FRCPC, MD;  Dongsheng Tu 1, PhD;  Ronald Holden 1, PhD;  Tanveer Towheed 1, FRCPC, MD;  Dan Ziegler 2, Prof Dr Med;  Louie Wang 1, MSc, FRCPC, MD;  Roumen Milev 1, FRCPC, MD, PhD;  Christopher Gray 3, CCRP

1 Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute , Kingston, ON, CA

2 Heinrich Heine University , Dusseldorf , DE

3 Kingston General Hospital , Kingston, ON, CA

Corresponding Author: